Listed

Perma Fix Environmental Services Inc: Form 10-Q for the period ended Mar 31, 2024

Filed with the SEC on May 9, 2024 and accepted by EDGAR at May 9, 2024, 14:42 ET.

Share

Management's discussion and analysis

As filed, 38,945 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Forward-looking Statements

Certain statements contained within this report may be deemed “forward-looking statements” within the meaning of the “Private Securities Litigation Reform Act of 1995”. All statements in this report other than a statement of historical fact are forward-looking statements that are subject to known and unknown risks, uncertainties and other factors, which could cause actual results and performance of the Company to differ materially from such statements. The words “believe,” “expect,” “anticipate,” “intend,” “will,” and similar expressions identify forward-looking statements. Forward-looking statements contained herein relate to, among other things,

  • demand for our services;
  • reductions in the level of government funding in future years;
  • accelerated investments and unanticipated impact on an ongoing basis;
  • base business is well positioned for the second half of 2024;
  • advancement of initiatives to have positive impact beginning in second half of 2024 and more fully realized in 2025;
  • reducing operating costs and non-essential expenditures;
  • ability to meet loan agreement quarterly covenant requirements;
  • cash flow requirements;
  • receipt of remaining Canadian receivable upon completion of conditions/terms of the settlement agreement in 2024;
  • sufficient liquidity to fund operations for the next twelve months;
  • revenue under the Italian project;
  • manner in which the applicable government will be required to spend funding to remediate various sites;
  • successful on international bids;
  • funding of operating and capital expenditures from cash from operations, cash on hand, borrowing availability under our credit facility, financing, and collection of Canadian receivables, when received;
  • our PFAS method is highly scalable process with minimal capital expenditures;
  • our PFAS technology process will exceed current treatment options;
  • installation of operational unit and accepting commercial waste for destruction by the end of the year;
  • funding of remediation expenditures for sites from funds generated internally;
  • compliance with environmental regulations;
  • value of Italian contract;
  • positioning for procurements from DOE and other government agencies;
  • potential effect of being a PRP; and
  • potential violations of environmental laws and attendant remediation at our facilities.

20

While the Company believes the expectations reflected in such forward-looking statements are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this report, including, but not limited to:

  • general economic conditions;
  • contract bids, including international markets;
  • material reduction in revenues;
  • inability to meet PNC covenant requirements;
  • inability to collect in a timely manner a material amount of receivables;
  • inability to collect Canadian receivables;
  • increased competitive pressures;
  • inability to maintain and obtain required permits and approvals to conduct operations;
  • inability to develop new and existing technologies in the conduct of operations;
  • inability to maintain and obtain closure and operating insurance requirements;
  • inability to retain or renew certain required permits;
  • discovery of additional contamination or expanded contamination at any of the sites or facilities leased or owned by us or our subsidiaries which would result in a material increase in remediation expenditures;
  • delays at our third-party disposal site can extend collection of our receivables greater than twelve months;
  • refusal of third-party disposal sites to accept our waste;
  • changes in federal, state and local laws and regulations, especially environmental laws and regulations, or in interpretation of such;
  • inability of the federal government to adopt a budget in a timely manner;
  • requirements to obtain permits for treatment, storage and disposal (TSD) activities or licensing requirements to handle low level radioactive materials are limited or lessened;
  • management retention and development;
  • financial valuation of intangible assets is substantially more/less than expected;
  • the need to use internally generated funds for purposes not presently anticipated;
  • inability of the Company to maintain the listing of its Common Stock on the Nasdaq;
  • terminations of contracts with government agencies or subcontracts involving government agencies or reduction in amount of waste delivered to the Company under the contracts or subcontracts;
  • failure of joint venture partner to perform its requirements in connection with the Italian project;
  • changes in the scope of work relating to existing contracts;
  • occurrence of an event similar to COVID-19 having adverse effects on the U.S. and world economics;
  • renegotiation of contracts involving government agencies;
  • disposal expense accrual could prove to be inadequate in the event the waste requires re-treatment;
  • inability to raise capital on commercially reasonable terms;
  • inability to increase profitable revenue;
  • economic uncertainties;
  • non-acceptance of our new technology;
  • new governmental regulations; and
  • risk factors and other factors set forth in “Special Note Regarding Forward-Looking Statements” contained in the Company’s 2023 Form 10-K and the “Forward-Looking Statements” contained in the Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”) of this first quarter 2024 10-Q.

21

Overview

As previously disclosed, our results of operations in the first quarter of 2024 were impacted by accelerated investments and several events, which included the following:

  • Accelerated investments in research and development (“R&D”) on our new technology to treat Per- and Polyfluorinated Substances (“PFAS”) (see “Known Trends and Uncertainties – New Processing Technology” within this MD&A for a discussion of this technology);
  • Reduced activities by our customers due to poor weather conditions, which resulted in the closure of two of our facilities for a week, including delays in shipments to support backlog;
  • Continuing Resolution impacts due to the inability of Congress to pass a Federal Budget through late March 2024, which contributed to delays in procurements, project starts and waste shipment, due to uncertain budget projections by our government clients;
  • Completion of two large projects in the Services Segment that were not replaced by new project starts due to delays in mobilization activities until late April; and
  • All three primary treatment facilities realized outages in March which impacted revenue as the Company utilized the aforementioned slowdowns for equipment replacement and repairs, program enhancements, and testing to support permit expansion and broader market penetration.

We believe that most of these accelerated investments and unanticipated impacts should have limited duration effects to our financial performance. We expect that the second quarter will not include material continued impact from these activities. With the passage of the Federal Budget in late March 2024 and improved weather conditions, we have begun to see steady improvements in waste receipts, project starts that were delayed and increased procurement activities. Our waste treatment backlog stands at approximately $10,580,000 as of March 31, 2024, an increase of approximately $1,878,000 from the December 31, 2023, balance of $8,702,000.

We believe our base business is well positioned for the second half of 2024 and, as previously reported, we continue to advance a variety of additional initiatives that we expect will have a further positive impact on both revenue and earnings beginning the second half of the year that are expected to be more fully realized in 2025. These initiatives include, among other things, positioning ourself for large and mid-size procurements within the U.S. Department of Energy (“DOE”) and U.S. Navy and waste treatment in support of DOE’s Hanford closure strategy, continued investments in our facilities and capabilities to allow for broader waste treatment, and continued expansion of our waste treatment offerings within the international and commercial markets. As previously disclosed, in December 2023, the JV where we and Campoverde Srl (“JV partner”) each owns 50% of the partnership, was awarded a multi-year contract valued up to approximately EUR 50 million by the European Commission (the “Contracting Authority”) for the treatment of radioactive waste from the Joint Research Center in Ispra, Italy. Work under this JV started in the first quarter of 2024. We generated limited revenue under this JV contract in the first quarter of 2024. The scope of work in the initial phases of this contract will be performed predominately by our JV partner. Revenue generated by us under the initial phases will be limited to project management support through 2025. We expect to generate an increase in revenue under this contract starting in 2026 when the waste treatment phases begin.

As a result of the aforementioned events which negatively impacted our results of operations for the first quarter of 2024, we incurred an overall decreased in revenue of approximately $6,490,000 or 32.3% to $13,617,000 for the three months ended March 31, 2024 from $20,107,000 for the corresponding period of 2023. Revenue decreased in both segments where Services Segment revenue decreased by $5,605,000 or 53.3% to $4,908,000 from $10,513,000 and Treatment Segment revenue decreased by $885,000 to $8,709,000 or 9.2% from $9,594,000. We incurred a gross loss in the first quarter of 2024 of approximately $620,000 as compared to a gross profit of $3,009,000 in the corresponding period of 2023, reflecting a decrease in gross profit of approximately $3,629,000 or 120.6%, primarily due to decreased revenue in both segments. Selling, General, and Administrative (“SG&A”) expenses increased by $58,000 or 1.7% for the three months ended March 31, 2024 as compared to the corresponding period of 2023 (see below “Results of Operations” for further discussions of our financial results).

Business Environment

Our Treatment and Services Segments’ business continues to be heavily dependent on services that we provide to governmental clients, primarily as subcontractors for others who are prime contractors to government entities or directly as the prime contractor. We believe demand for our services will continue to be subject to fluctuations due to a variety of factors beyond our control, including, without limitation, the economic conditions, the manner in which the applicable government will be required to spend funding to remediate various sites and potential future federal budget issues. In addition, our governmental contracts and subcontracts relating to activities at governmental sites in the United States are generally subject to termination for convenience at any time at the government’s option. Our Italian contract under our JV as discussed above may be terminated by the Contracting Authority under certain conditions as set forth in the contract. Significant reductions in the level of governmental funding or specifically mandated levels for different programs that are important to our business could have a material adverse impact on our business, financial position, results of operations, and cash flows.

We are reviewing methods to raise additional capital to supplement our liquidity requirements (see “Liquidity and Capital Resources” below for a discussion of our liquidity). We continue to aggressively bid on various contracts, including potential contracts within the international markets.

Results of Operations

The reporting of financial results and pertinent discussions are tailored to our two reportable segments: The Treatment and Services.

Summary – Three Months Ended March 31, 2024 and 2023

Three Months Ended March 31,
Consolidated (amounts in thousands) 2024% 2023%
Revenues $13,617 100.0 $20,107 100.0
Cost of good sold 14,237 104.6 17,098 85.0
Gross (loss) profit (620) (4.6) 3,009 15.0
Selling, general and administrative 3,544 26.0 3,486 17.3
Research and development 296 2.2 99 .5
Loss from operations $(4,460) (32.8) $(576) (2.8)
Interest income 174 1.3 127 .6
Interest expense (116) (.8) (53) (.3)
Interest expense-financing fees (13) (.1) (20) (.1)
Other 1 — — —
Loss from continuing operations before taxes (4,414) (32.4) (522) (2.6)
Income tax benefit (956) (7.0) (204) (1.0)
Loss from continuing operations $(3,458) (25.4) $(318) (1.6)

23

Revenues

Consolidated revenues decreased $6,490,000 for the three months ended March 31, 2024, compared to the three months ended March 31, 2023, as follows:

(In thousands)

Treatment 2024 % Revenue 2023 % Revenue Change % Change
Government waste $5,133 37.7 $6,642 33.0 $(1,509) (22.7)
Hazardous/non-hazardous (1) 1,337 9.8 1,511 7.5 (174) (11.5)
Other nuclear waste 2,239 16.5 1,441 7.2 798 55.4
Total 8,709 64.0 9,594 47.7 (885) (9.2)
Services
Nuclear services 4,569 33.5 10,082 50.1 (5,513) (54.7)
Technical services 339 2.5 431 2.1 (92) (21.3)
Total 4,908 36.0 10,513 52.3 (5,605) (53.3)
Total $13,617 100.0 $20,107 100.0 $(6,490) (32.3)

(1) Includes wastes generated by government clients of $628,000 and $710,000 for the three months ended March 31, 2024 and the corresponding period of 2023, respectively.

Treatment Segment revenue decreased by $885,000 or 9.2% for the three months ended March 31, 2024, over the same period in 2023. The decrease in revenue generated from government clients was primarily due to lower waste volume attributed from the events as discussed in the “Overview” section above which included delays in waste shipments due to poor weather conditions and from Continuing Resolution impact due to the inability of Congress to timely pass the Federal Budget. The increase in other nuclear waste revenue was primarily due to higher waste volume which included increased revenue generated from commercial and international clients. The overall revenue within our Treatment Segment was also negatively impacted by delays in waste treatment production and waste receipts due to temporary outages of our facilities as previously discussed. Overall lower averaged price from waste mix within the Treatment Segment also contributed to the revenue decrease. Services Segment revenue decreased by approximately $5,605,000 or 53.3%. The decrease in revenue in the Services Segment was due in part, to the completion of two large projects which were not replaced by new project starts due to delays in mobilization activities until late April 2024 from the impact of the Continuing Resolution as previously discussed. Additionally, our Services Segment revenues are project based; as such, the scope, duration, and completion of each project vary. Revenues from both segments were also negatively impacted from delays in procurements resulting from the impact of Continuing Resolutions.

Cost of Goods Sold

Cost of goods sold decreased $2,861,000 for the quarter ended March 31, 2024, compared to the quarter ended March 31, 2023, as follows:

(In thousands)

2024 %% Revenue 2023 Revenue Change
Treatment $8,761 100.6 $8,342 87.0 $419
Services 5,476 111.6 8,756 83.3 (3,280)
Total $14,237 104.6 $17,098 85.0 $(2,861)

Cost of goods sold for the Treatment Segment increased by approximately $419,000 or 5.0%. Treatment Segment’s variable costs increased by approximately $506,000 primarily due to higher disposal costs. Treatment Segment’s overall fixed costs were lower by approximately $87,000 resulting from the following: general expenses were lower by $238,000 primarily due to lower utility costs; depreciation expenses were lower by approximately $206,000 due to fully depreciated asset retirement obligations that occurred in the third quarter of 2023 in connection with our EWOC facility; maintenance expenses were lower by approximately $42,000; regulatory expenses were higher by approximately $53,000; salaries and payroll related expenses were higher by $335,000 due to higher headcount; and travel expenses were higher by approximately $11,000. Services Segment cost of goods sold decreased $3,280,000 or 37.5% primarily due to lower revenue. The decrease in cost of goods sold was primarily due to lower salaries/payroll related, outside services, and travel costs totaling approximately $2,870,000; lower material and supplies, lab and regulatory expenses totaling approximately $316,000; lower depreciation expense totaling approximately $115,000; and slightly higher general expenses by approximately $21,000 in various categories. Included within cost of goods sold is depreciation and amortization expense of $404,000 and $726,000 for the three months ended March 31, 2024, and 2023, respectively.

Gross (loss) profit

Gross profit decreased 3,629,000 for the quarter ended March 31, 2024, compared to the quarter ended March 31, 2023, as follows:

(In thousands)

2024 %% Revenue 2023 Revenue Change
Treatment $(52) (0.6) $1,252 13.0 $(1,304)
Services (568) (11.6) 1,757 16.7 (2,325)
Total $(620) (4.6) $3,009 15.0 $(3,629)

Treatment Segment gross profit decreased by $1,304,000 or approximately 104.2% and gross margin decreased to (0.6)% from 13.0% primarily due to lower revenue from lower waste volume, overall lower averaged price from waste mix and the impact of our fixed costs structure. Services Segment gross profit decreased by $2,325,000 or 132.3% primarily due to decreased revenue resulting from the completion of the two large projects as previously disclosed. The decrease in gross margin from 16.7% to (11.6)% was attributed to overall lower margin projects as the two large completed projects were higher margin projects. Our overall Services Segment gross margin is impacted by our current projects which are competitively bid on and will therefore, have varying margin structures.

SG&A

SG&A expenses increased $58,000 for the three months ended March 31, 2024, as compared to the corresponding period for 2023, as follows:

(In thousands)

2024 %% Revenue 2023 Revenue Change
Administrative $1,687 — $1,670 — $17
Treatment 1,065 12.2 1,006 10.5 59
Services 792 16.1 810 7.7 (18)
Total $3,544 26.0 $3,486 17.3 $58

Administrative SG&A expenses were higher primarily due to higher travel, outside services and general expenses totaling approximately $29,000 which was offset by lower salaries and payroll related expenses totaling approximately $12,000. Treatment Segment SG&A expenses were higher primarily due to overall higher salaries and payroll related expenses by approximately $91,000 which was offset by lower general expenses in various categories. The decrease in Services Segment SG&A was primarily due to lower outside services expenses resulting from fewer consulting and legal matters. Included in SG&A expenses is depreciation and amortization expense of $27,000 and $21,000 for the three months ended March 31, 2024 and 2023, respectively.

R&D

R&D expenses increased by approximately $197,000 in the first quarter of 2024 as compared to the corresponding period of 2023 primarily due to expenses incurred for our PFAS technology (see “Known Trends and Uncertainties – New Processing Technology” within this MD&A for a discussion of this technology).

Interest Income

Interest income increased by approximately $47,000 in the first quarter of 2024 as compared to the corresponding period of 2023 primarily due to higher interest earned from our finite risk sinking fund and interest income earned from our money market deposit account that we maintained with our lender starting in late 2023. The overall increase in interest income from the above was reduced by interest income received in March of 2023 of approximately $60,000 in connection with the Employee Retention Credit refund that we received.

Interest Expense

Interest expense increased by approximately $63,000 in the first quarter of 2024 as compared to the corresponding period of 2023 primarily due to interest incurred on the $2,500,000 term loan dated July 31, 2023, under our credit facility.

Income Taxes

We had income tax benefits of approximately $956,000 and $204,000 for continuing operations for the three months ended March 31, 2024, and 2023, respectively. Our effective tax rate was approximately 21.7% and 39.1% for the three months ended March 31, 2024, and the corresponding period of 2023, respectively. Our tax rates for the three months ended March 31, 2024, and 2023 were impacted by non-deductible expenses and state taxes.

Liquidity and Capital Resources

Our cash flow requirements during the three months ended March 31, 2024, were primarily financed by our operations, cash on hand, and credit facility availability. Our cash flow requirements for the next twelve months will consist primarily of general working capital needs, scheduled principal payments on our debt obligations, remediation projects, and planned capital expenditures which include our PFAS technology (see “Known Trends and Uncertainties – New Processing Technology” within this MD&A for a discussion of this technology). We plan to fund these requirements from our operations, credit facility availability, cash on hand (which will include, when received, cash from outstanding receivables due to our Perma-Fix Canada, Inc. subsidiary from a certain customer - See “Known Trends and Uncertainties – Perma-Fix Canada, Inc. (“PF Canada”)” for a discussion of this outstanding receivables) and possible other methods. Our ability to utilize our credit facility from our lender is subject to meeting our quarterly financial covenant requirements, among other things. We continue to explore all sources of increasing our capital and/or liquidity and to improve our revenue and working capital, including, but not limited to entering into equity transactions. There are no assurances that we will be successful in increasing our liquidity through our efforts. We are continually reviewing operating costs and reviewing the possibility of further reducing operating costs and non-essential expenditures to bring them in line with revenue levels, when necessary. As of March 31, 2024, our borrowing availability under our revolving part of our credit facility was approximately $2,379,000, which included our cash (deposited with our lender) and was based on our eligible receivables and was net of approximately $3,950,000 in outstanding standby letters of credit and a $750,000 indefinite reduction in borrowing availability that our lender imposed. We believe that our cash flows from operations, our available liquidity from our credit facility, and our cash on hand (which will include, when received, cash from the outstanding Canadian receivables noted above) should be sufficient to fund our operations for the next twelve months.

The following table reflects the cash flow activities during the first three months of 2024:

(In thousands)

Cash used in operating activities of continuing operations $(4,432)
Cash used in operating activities of discontinued operations (159)
Cash used in investing activities of continuing operations (244)
Cash used in financing activities of continuing operations (125)
Effect of exchange rate on cash (18)
Decrease in cash and finite risk sinking fund (restricted cash) $(4,978)

As of March 31, 2024, we were in a positive cash position with no revolving credit balance. As of March 31, 2024, we had cash on hand of approximately $2,374,000. which included account balances of our foreign subsidiaries totaling approximately $837,000.

Operating Activities

Accounts receivable, net of credit losses, totaled $8,701,000 as of March 31, 2024, a decrease of $1,021,000 from the December 31, 2023, balance of $9,722,000. The decrease was primarily due to reduced billing from decreased revenues which were negatively impacted by a number of events as previously discussed (See “Overview” within this MD&A). Our accounts receivable at March 31, 2024, included invoices for work performed for a certain Canadian project that remained outstanding for which a settlement agreement has been reached, with collection subject to meeting certain conditions/terms precedent (See discussion under “Known Trends and Uncertainties - Perma-Fix Canada Inc. (“PF Canada”)” below for a discussion of the accounts receivable that remains payable by our customer to PF Canada).

Accounts payable totaled $7,979,000 as of March 31, 2024, a decrease of $1,603,000 from the December 31, 2023, balance of $9,582,000. The decrease in accounts payable was attributed to our overall reduced operations as discussed previously. Additionally, or accounts payable are impacted by the timing of payments as we are continually managing payment terms with our vendors to maximize our cash position throughout our segments.

We had working capital of $255,000 (which included working capital of our discontinued operations) as of March 31, 2024, as compared to working capital of $4,613,000 as of December 31, 2023. The decrease in our working capital was primarily due to the reduction in our cash which was significantly impacted by the revenue decreases in both segments as previously discussed.

Investing Activities

For the three months ended March 31, 2024, our purchases of capital equipment totaled approximately $288,000, of which $44,000 was subject to financing, with the remaining funded from cash from operations and our credit facility. We have budgeted approximately $2,000,000 for 2024 capital expenditures primarily for our Treatment and Services Segments to maintain operations and regulatory compliance requirements and support revenue growth. Certain of these budgeted projects may either be delayed until later years or deferred altogether. We plan to fund our capital expenditures from cash from operations, borrowing availability under our credit facility and/or financing. The initiation and timing of projects are also determined by financing alternatives or funds available for such capital projects.

Financing Activities

We entered into a Second Amended and Restated Revolving Credit, Term Loan and Security Agreement, dated May 8, 2020 (“Loan Agreement”), with PNC National Association (“PNC” and “lender”), acting as agent and lender. The Loan Agreement, as amended from time to time, provides us with the following credit facility with a maturity date of May 15, 2027: (a) up to $12,500,000 revolving credit (“revolving credit”), with the maximum that we can borrow under the revolving credit based on a percentage of eligible receivables (as defined) at any one time reduced by outstanding standby letters of credit and borrowing reductions that our lender may impose from time to time; (b) a term loan (“Term Loan 1”) of approximately $1,742,000, requiring monthly installments of $35,547; (c) a term loan (“Term Loan 2”) of $2,500,000, requiring monthly installments of $41,667; and (d) a capital expenditure line (“Capital Line”) of up to $1,000,000 with advances on the line, subject to certain limitations, permitted for up to twelve months starting May 4, 2021 (the “Borrowing Period”). Amounts advanced under the Capital Line at the end of the Borrowing Period totaled approximately $524,000, requiring monthly installments of principal of approximately $8,700 plus interest, commencing June 1, 2022.

On May 8, 2024, we entered into an amendment to our Loan Agreement, as amended, with our lender which provided the following, among other things:

  • removes the quarterly FCCR testing requirement for the first and second quarters of 2024;
  • reinstates the quarterly FCCR testing requirement starting in the third quarter of 2024 and revises the methodology to be used in calculating the FCCR as follows (with no change to the minimum 1.15:1 ratio requirement): FCCR for the third quarter is to be determined based on financial results for the three-months period ending September 30, 2024; FCCR for the fourth quarter is to be determined based on financial results for the six-months period ending December 31, 2024; FCCR for the first quarter of 2025 is to be determined based on financial results for the nine-months period ending March 31, 2025; and FCCR for the second quarter of 2025 and each fiscal quarter thereafter is to be determined based on financial results for a trailing twelve-months period ending basis;
  • requires maintenance of a daily minimum $2,250,000 in borrowing availability under the revolving credit through June 29, 2024, and a minimum of $3,000,000 in borrowing availability starting June 30, 2024, through June 29, 2025; and
  • in the event we are able to achieve the minimum quarterly FCCR requirement utilizing our financial results based on a trailing twelve-months period starting with the quarter ending June 30, 2024, the maintenance of a daily minimum borrowing availability requirement of $3,000,000 as discussed above will be removed. Any subsequent fiscal quarter testing of the FCCR will revert back to a trailing twelve-months period method.

In connection with the amendment, we paid our lender a fee of $25,000.

Pursuant to our Loan Agreement, as amended, payments of annual interest rates are as follows: (i) interest due on the revolving credit is at prime (8.50% at March 31, 2024) plus 2% or SOFR (as defined in the Loan Agreement, as amended) plus 3.00% plus an SOFR Adjustment applicable for an interest period selected by us; (ii) interest due on each Term Loan 1 and the Capital Line is at prime plus 2.50% or SOFR plus 3.50% plus an SOFR Adjustment applicable for an interest period selected by us; and (iii) interest due on Term Loan 2 is at prime plus 3% or SOFR plus 4.00% plus an SOFR Adjustment applicable for an interest period selected by us. SOFR Adjustment rates of 0.10% and 0.15% are applicable for a one-month interest period and three-month period, respectively, that may be selected by us.

We agreed to pay PNC 1.0% of the total financing under the Loan Agreement, as amended, in the event we pay off our obligations on or before July 31, 2024, and 0.5% of the total financing if we pay off our obligations after July 31, 2024, to and including July 31, 2025. No early termination fee shall apply if we pays off our obligations under Loan Agreement, as amended, after July 31, 2025.

Our credit facility under our Loan Agreement, as amended, with PNC contains certain financial covenants, along with customary representations and warranties. A breach of any of these financial covenants, unless waived by PNC, could result in a default under our credit facility allowing our lender to immediately require the repayment of all outstanding debt under our credit facility and terminate all commitments to extend further credit. We were not required to perform testing of our FCCR requirement for the first quarter of 2024 pursuant to the amendment dated May 8, 2024, to our Loan Agreement, as amended, as discussed above. We met all of our other financial covenant requirements in the first quarter of 2024. We expect to meet our quarterly financial covenant requirements for the next twelve months under our Loan Agreement, as amended, pursuant to the terms of the amendment dated May 8, 2024, as discussed above.

Off Balance Sheet Arrangements

From time to time, we are required to post standby letters of credit and various bonds to support contractual obligations to customers and other obligations, including facility closures. At March 31, 2024, the total amount of standby letters of credit outstanding totaled approximately $3,950,000 and the total amount of bonds outstanding totaled approximately $26,747,000. We also provide closure and post-closure requirements through a financial assurance policy for certain of our Treatment Segment facilities through AIG. At March 31, 2024, the closure and post-closure requirements for these facilities were approximately $23,376,000.

Critical Accounting Policies and Estimates

There were no significant changes in our accounting policies or critical accounting estimates that are discussed in our Annual Report on Form 10-K for the year ended December 31, 2023.

Recent Accounting Pronouncements

See “Note 2 – Summary of Significant Accounting Policies” in the “Notes to Condensed Consolidated Financial Statements” for the recent accounting pronouncements that will be adopted in future periods.

Known Trends and Uncertainties

Significant Customers. The contracts that we are a party to with others as subcontractors to the U.S federal government or directly with the U.S federal government generally provide that the government may terminate the contract at any time for convenience at the government’s option. Our Italian contract under the JV may be terminated by the Contracting Authority under certain conditions as set forth in the contract. Our inability to continue under existing contracts that we have with government authorities (directly or indirectly as a subcontractor) or significant reductions in the level of governmental funding in any given year could have a material adverse impact on our operations and financial condition. We performed services relating to waste generated by government clients, either indirectly as a subcontractor or directly as a prime contractor to government entities, representing approximately $10,143,000 or 74.5% of our total revenue during the three months ended March 31, 2024, as compared to $17,247,000 or 85.8%of our total revenue during the corresponding period of 2023.

PF Canada. During the fourth quarter of 2021, PF Canada received a Notice of Termination (“NOT”) from CNL on a Task Order Agreement (“TOA”) that PF Canada entered into with CNL in May 2019 for remediation work within Ontario, Canada (“Agreement”). The NOT was received after work under the TOA was substantially completed and work under the TOA has since been completed. CNL may terminate the TOA at any time for convenience. At year-end 2023, PF Canada had approximately $2,389,000 in outstanding receivables due from CNL as a result of work performed under the TOA. A settlement agreement was reached between PF Canada and CNL on the payment of the aforementioned amount by CNL, subject to certain conditions/terms precedents being met, including release of certain liens. We received a partial payment from CNL of the outstanding receivables during the first quarter of 2024. As of March 31, 2024, approximately $1,612,000 in outstanding receivables remain payable by CNL to PF Canada upon completion of the settlement conditions/terms, which the Company believes should occur by the end of 2024.

New Processing Technology. We have successfully completed pilot plant testing on our new, patent-pending process for the destruction of PFAS, commonly known as “forever chemicals.” PFAS compounds do not degrade over time through any natural process or environmental conditions, bioaccumulate, and are harmful to humans and the environment. Our tests were designed to demonstrate the destruction of commercial quantities of PFAS-contaminated liquids and better define the parameters needed to construct the first commercial unit. There are limited current treatment options for these materials and we expect that our process will exceed any of these methods. Some of the sizable markets for PFAS include AFFF (aqueous film-forming foam) firefighting foams, both expired concentrate and flushing liquids, contaminated liquids from PFAS systems, and other water-based separation products from a variety of industrial systems. We believe that our process is highly scalable with minimal capital expenditures or labor costs required since we are employing a non-incineration, chemical-based process. We are now in the process of final design and fabrication for installation of the first operational unit and plan to be operational, accepting commercial waste for destruction by the end of the year. We have established goals for additional units to be installed at each existing treatment plant to follow in 2025.

Environmental Contingencies

We are engaged in the waste management services segment of the pollution control industry. As a participant in the on-site treatment, storage and disposal market and the off-site treatment and services market, we are subject to rigorous federal, state and local regulations. These regulations mandate strict compliance and therefore are a cost and concern to us. Because of their integral role in providing quality environmental services, we make every reasonable attempt to maintain complete compliance with these regulations; however, even with a diligent commitment, we, along with many of our competitors, may be required to pay fines for violations or investigate and potentially remediate our waste management facilities.

We routinely use third party disposal companies, who ultimately destroy, or secure landfill residual materials generated at our facilities or at a client’s site. In the past, numerous third-party disposal sites have improperly managed waste and consequently require remedial action; consequently, any party utilizing these sites may be liable for some or all of the remedial costs. Despite our aggressive compliance and auditing procedures for disposal of wastes, we could further be notified, in the future, that we are a potentially responsible party (“PRP”) at a remedial action site, which could have a material adverse effect.

We have three environmental remediation projects, all within our discontinued operations, which principally entail the removal/remediation of contaminated soil, and, in most cases, the remediation of surrounding ground water. We expect to fund the expenses to remediate these sites from funds generated from operations. As of March 31, 2024, we had total accrued environmental remediation liabilities of $800,000, a decreased of approximately $45,000 from the December 31, 2023 balance of $845,000. The decrease represents payments for remediation projects. At March 31, 2024, $16,000 of the total accrued environmental liabilities was recorded as current.

Controls and procedures

As filed, 1,312 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) Evaluation of disclosure controls, and procedures.

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed with the Securities and Exchange Commission is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to our management. As of the end of the period covered by this report, we carried out an evaluation with the participation of our Principal Executive Officer and Principal Financial Officer. Based on this recent assessment, our Principal Executive Officer and Principal Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended) were effective as of March 31, 2024.

(b) Changes in internal control over financial reporting

There was no other change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during our most recently completed fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 1,422 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There has been no other material change from the risk factors previously disclosed in our Form 10-K for the year ended December 31, 2023, except for the following under “Risks Relating to our Financial Performance and Position and Need for Financing.”

Breach of any of the covenants, including the fixed charge coverage ratio under our Loan Agreement, as amended, could result in a default, triggering repayment of outstanding debt under the credit facility and the termination of our credit facility.

From time to time, the Company has failed to meet its minimum quarterly fixed charge coverage ratio requirement under its Loan Agreement, as amended, as in the first quarter of 2024. In these instances, the Company’s lender has either waived the non-compliance or removed the testing requirement for the quarter. The Company’s lender has removed the testing requirement for the fixed charge coverage ratio for the first and second quarters of 2024. If we fail to meet any of our financial covenants going forward, including the minimum quarterly FCCR requirement, and our lender does not waive the non-compliance or remove the testing requirement, our lender could accelerate the payment of our borrowings under our credit facility and terminate our credit facility. In such event, we may not have sufficient liquidity to repay our debt under our credit facility and other indebtedness and/or operate our business.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-01-01 to 2024-03-31$13.6mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2024-01-01 to 2024-03-31$14.2mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2024-01-01 to 2024-03-31−$620.0kus-gaap:GrossProfit
Research and development3 months2024-01-01 to 2024-03-31$296.0kus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2024-01-01 to 2024-03-31$3.5mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2024-01-01 to 2024-03-31−$4.5mus-gaap:OperatingIncomeLoss
Interest expense3 months2024-01-01 to 2024-03-31$116.0kus-gaap:InterestExpense
Income tax3 months2024-01-01 to 2024-03-31−$956.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-01-01 to 2024-03-31−$3.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-01-01 to 2024-03-31−$0.26us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-01-01 to 2024-03-31−$0.26us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-01-01 to 2024-03-3113,676,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow3 months2024-01-01 to 2024-03-31−$4.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure3 months2024-01-01 to 2024-03-31$244.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2024-03-31$2.4mus-gaap:Cash
Current assetsAt period end2024-03-31$24.9mus-gaap:AssetsCurrent
Total assetsAt period end2024-03-31$74.0mus-gaap:Assets
Current liabilitiesAt period end2024-03-31$24.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-03-31$37.8mus-gaap:Liabilities
Long-term debtAt period end2024-03-31$1.9mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2024-03-31$673.0kus-gaap:LongTermDebtCurrent

Source: SEC EDGAR, the filing index for accession 0001493152-24-018390. Last ingested by Listed: Nov 13, 2026, 07:07 ET. Listed shows no prices and gives no investment advice.